Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Gynecologic and Obstetric Investigation|October 10, 2008
Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reportsI Vandenput, I Vanden Bempt, K Leunen, et al.
British Journal of Cancer|July 2, 2009
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?I Vandenput, B Van Calster, A Capoen, et al.
British Journal of Cancer|February 10, 2011
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy AlgorithmT Van Gorp, I Cadron, E Despierre, et al.
Gynecologic Oncology|April 6, 2013
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapyE Despierre, S Lambrechts, K Leunen, et al.
British Journal of Cancer|September 27, 2007
Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcomaF Amant, A De Knijf, B Van Calster, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapyS Pignata, F Amant, G Scambia, et al.
Gynecologic Oncology|August 31, 2013
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancerH Dauwen, B Van Calster, C M Deroose, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2013
Long-term results of weekly paclitaxel carboplatin induction therapy: an effective and well-tolerated treatment in patients with platinum-resistant ovarian cancerM E L van der Burg, I Vergote, W Onstenk, et al.
Breast Cancer Research and Treatment|May 13, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMIA Lintermans, K Van Asten, H Wildiers, et al.
Breast Cancer Research and Treatment|May 13, 2011
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patientsT Vandorpe, A Smeets, B Van Calster, et al.
Pageof 4